| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |